| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President, CEO
2 companies
King Rachel K. is a Director at CRESCENT BIOPHARMA, INC. with holdings across 2 companies. Recent SEC Form 4 filings include 4 buys and 2 sells.
Estimated insider holdings value: $9.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 13, 2024 | NVAX Novavax Inc | Director | Sell | 4,150 | $9.02 | $37,435.08 | -21.9% | -10.3% | -27.9% | |
| May 19, 2021 | NVAX Novavax Inc | Director | Buy | 700 | $139.64 | $97,748.00 | +33.3% | +65.0% | -58.9% | |
| Dec 28, 2020 | CBIO Crescent Biopharma, Inc. | President, CEO | Sale+OE | 84,176 | $3.91 | $329,128.16 | -19.1% | - | - | |
| Mar 27, 2019 | NVAX Novavax Inc | Director | Buy | 86,000 | $0.53 | $45,562.80 | New | - | - |